Adhesive Organelles of Gram-negative Pathogens Assembled with the Classical Chaperone/usher Machinery: Structure and Function from a Clinical Standpoint
Overview
Affiliations
This review summarizes current knowledge on the structure, function, assembly and biomedical applications of the superfamily of adhesive fimbrial organelles exposed on the surface of Gram-negative pathogens with the classical chaperone/usher machinery. High-resolution three-dimensional (3D) structure studies of the minifibers assembling with the FGL (having a long F1-G1 loop) and FGS (having a short F1-G1 loop) chaperones show that they exploit the same principle of donor-strand complementation for polymerization of subunits. The 3D structure of adhesive subunits bound to host-cell receptors and the final architecture of adhesive fimbrial organelles reveal two functional families of the organelles, respectively, possessing polyadhesive and monoadhesive binding. The FGL and FGS chaperone-assembled polyadhesins are encoded exclusively by the gene clusters of the γ3- and κ-monophyletic groups, respectively, while gene clusters belonging to the γ1-, γ2-, γ4-, and π-fimbrial clades exclusively encode FGS chaperone-assembled monoadhesins. Novel approaches are suggested for a rational design of antimicrobials inhibiting the organelle assembly or inhibiting their binding to host-cell receptors. Vaccines are currently under development based on the recombinant subunits of adhesins.
Bacterial biofilms in the human body: prevalence and impacts on health and disease.
Perry E, Tan M Front Cell Infect Microbiol. 2023; 13:1237164.
PMID: 37712058 PMC: 10499362. DOI: 10.3389/fcimb.2023.1237164.
Urinary Tract Infections Caused by Uropathogenic : Mechanisms of Infection and Treatment Options.
Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y Int J Mol Sci. 2023; 24(13).
PMID: 37445714 PMC: 10341809. DOI: 10.3390/ijms241310537.
Targeting BAM for Novel Therapeutics against Pathogenic Gram-Negative Bacteria.
Cottom C, Stephenson R, Wilson L, Noinaj N Antibiotics (Basel). 2023; 12(4).
PMID: 37107041 PMC: 10135246. DOI: 10.3390/antibiotics12040679.
Reichhardt C J Bacteriol. 2023; 205(5):e0001923.
PMID: 37098957 PMC: 10210978. DOI: 10.1128/jb.00019-23.
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.
Kon E, Levy Y, Elia U, Cohen H, Hazan-Halevy I, Aftalion M Sci Adv. 2023; 9(10):eadg1036.
PMID: 36888708 PMC: 9995031. DOI: 10.1126/sciadv.adg1036.